Vol. 35 No. 6 (2018): Diciembre
Infección por VIH/SIDA

Evaluation of bone mineral density in children with vertical infection by HIV

Claudia Torrejón
Universidad de Chile.
M. Isabel Galaz
Hospital Roberto del Río
Eloísa Vizueta
Hospital San Borja Arriarán
Ana M. Álvarez
Hospital San Juan de Dios
Elba Wu
Hospital San Juan de Dios
Ana Chávez
Hospital Exequiel González Cortés
Julia Villarroel
Hospital Félix Bulnes Cerda
Karla Yohannessen
Universidad de Chile
Mariana Hevia
Universidad de los Andes
Maritza Vivanco
Hospital Roberto del Río
Constanza Rivero
Universidad de Chile
Paulina Balboa
Universidad de Chile

Published 2018-12-30

How to Cite

1.
Torrejón C, Galaz MI, Vizueta E, Álvarez AM, Wu E, Chávez A, Villarroel J, Yohannessen K, Hevia M, Vivanco M, Rivero C, Balboa P. Evaluation of bone mineral density in children with vertical infection by HIV. Rev. Chilena. Infectol. [Internet]. 2018 Dec. 30 [cited 2026 Jan. 29];35(6). Available from: https://revinf.cl/index.php/revinf/article/view/320

Abstract

Changes in bone mineral density (BMD) are common in adults infected with human immunodeficiencyvirus (HIV). There are few studies evaluating bone involvement in children infected. Objective: To evaluate BMD in vertically HIV-infected children. Methods: We studied 53 infected children (8-18 years) from fivehospitals. Disease status, nutritional assessment, vitamin D (25-OHD) levels and immunological status were recorded. BMD was measured by densitometry. Descriptive analysis, comparison of means and simple and multiple linear regression were used. Results: 88.7% children were in stage B and C, 57% were eutrophic and 18.9% had short stature. 33.3% had 25-OHD levels ˂ 20 ng / ml. 11%, 6% and 4% of the children had BMD <-2DE in hip, spine and whole body respectively. BMD was correlated with BMI, height, disease stage and years of treatment. Only protease inhibitors (PIs) maintained their significancewhen adjusted for other variables. Conclusion: children infected with HIV had lower BMD by age compared to NHANES III data. The severity of the disease, height, zBMI, years of treatment with antiretrovirals, mainly IP, are related to the reduction of bone mass.